Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Post by SanFrancisco99on May 05, 2015 2:53pm

189 Views

Post# 23696218

Stockhouse and RVX

I've been having a lot of trouble for some time connecting to Stockhouse. Oftentimes, the website appears to be down.

I'm curious to know if other Rvx investors are having the same issues.

I recall that the RVX "conversation" was first on Investor Village mostly. Later, most people switched to Stockhouse as it seemed to be a better forum since they don't charge fees in order to post....

But the "new" Stockhouse website is terrible. And seems to be unreliable.

I wonder if it is time to move to another forum for the conversation. I'm starting to loose patience with Stockhouse.

Anyone else feel the same way?

Bullboard Posts

MDA Space stock blasts off on Q3 financial results